Daniel Arias
Stock Analyst at Stifel
(5.00)
# 9
Out of 4,828 analysts
153
Total ratings
51.69%
Success rate
146.03%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $57 → $48 | $37.52 | +27.93% | 7 | May 8, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $49.94 | +20.14% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $41.72 | +43.82% | 3 | May 1, 2025 | |
| AVTR Avantor | Downgrades: Hold | $26 → $14 | $12.02 | +16.47% | 9 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $403.13 | +53.80% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $189.73 | +37.04% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.36 | +282.17% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $8.77 | +105.25% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $5.62 | +6.76% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,080.98 | +34.14% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $61.37 | +5.91% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $51.63 | +29.77% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $344.06 | +4.63% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $106.93 | +41.21% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $41.86 | +10.73% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.99 | +403.78% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $123.20 | +68.03% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $91.25 | +20.55% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $75.76 | +163.99% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.46 | +103.25% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.75 | +263.64% | 2 | May 31, 2022 |
Bruker
May 8, 2025
Maintains: Hold
Price Target: $57 → $48
Current: $37.52
Upside: +27.93%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $49.94
Upside: +20.14%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $41.72
Upside: +43.82%
Avantor
Apr 28, 2025
Downgrades: Hold
Price Target: $26 → $14
Current: $12.02
Upside: +16.47%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $403.13
Upside: +53.80%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $189.73
Upside: +37.04%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.36
Upside: +282.17%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $8.77
Upside: +105.25%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $5.62
Upside: +6.76%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,080.98
Upside: +34.14%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $61.37
Upside: +5.91%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $51.63
Upside: +29.77%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $344.06
Upside: +4.63%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $106.93
Upside: +41.21%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $41.86
Upside: +10.73%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $1.99
Upside: +403.78%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $123.20
Upside: +68.03%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $91.25
Upside: +20.55%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $75.76
Upside: +163.99%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.46
Upside: +103.25%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.75
Upside: +263.64%